Safety Communications > UPDATE: Zoll LifeVest 4000 Wearable Cardioverter Defibrillator - Potential Lack of Treatment (Shock) Delivery Due to Device Failure: FDA Safety Communication

Safety Communications > UPDATE: Zoll LifeVest 4000 Wearable Cardioverter Defibrillator - Potential Lack of Treatment (Shock) Delivery Due to Device Failure: FDA Safety Communication

An update to a previous MedWatch Safety Alert: Zoll LifeVest 4000 Wearable Cardioverter Defibrillator - Potential Lack of Treatment (Shock) Delivery Due to Device Failure: FDA Safety Communicationintended for: Patient, Cardiology, Risk Manager, Nursing was just added to the FDA Medical Device Safety Communication page.

 

You can read the complete Updated Safety Communication that includes recommendations at: https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm614559.htm